Comparative Pharmacology
Head-to-head clinical analysis: PRISMASOL B22GK 2 0 IN PLASTIC CONTAINER versus PRISMASOL BGK 4 0 IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: PRISMASOL B22GK 2 0 IN PLASTIC CONTAINER versus PRISMASOL BGK 4 0 IN PLASTIC CONTAINER.
PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER vs PRISMASOL BGK 4/0 IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Prismasol B22GK 2/0 is a solution used in continuous renal replacement therapy (CRRT) to correct electrolyte imbalances and remove waste products. It provides bicarbonate as a buffer via metabolism of lactate or acetate, and contains electrolytes to maintain homeostasis.
Hemodialysis solution components correct electrolyte imbalances and acid-base disturbances via diffusion and ultrafiltration across a semipermeable membrane.
Continuous renal replacement therapy (CRRT): prescription as per institutional protocol, typically 2000-2500 mL/h effluent rate (dialysate + replacement fluid) for adults. Peritoneal dialysis: 2-3 L exchanges, 4-5 times daily or cycler. Intravenous infusion only via CRRT or as dialysate/replacement fluid.
Intravenous continuous renal replacement therapy (CRRT) using Prismasol BGK 4/0. Typical flow rate: dialysate and replacement fluid at 2000-3000 mL/h, adjusted to achieve desired solute clearance and fluid balance. Dose individualized based on patient size, metabolic rate, and clinical status.
None Documented
None Documented
Not applicable; PRISMASOL B22GK 2/0 is a dialysate solution for CRRT. Components (glucose, electrolytes, lactate/bicarbonate) are continuously removed and replaced. For buffer conversion: lactate half-life ~5 minutes (hepatic metabolism to bicarbonate).
Not applicable as a replacement solution; components follow endogenous kinetics. For bicarbonate buffer, half-life is minutes due to rapid equilibration; for electrolytes, half-life depends on CRRT clearance.
Renal (100%); eliminated unchanged by ultrafiltration and diffusion during continuous renal replacement therapy (CRRT). Biliary/fecal: negligible.
PRISMASOL BGK 4/0 is a replacement solution for continuous renal replacement therapy (CRRT); its components (electrolytes, buffer) are primarily eliminated via the CRRT circuit (ultrafiltration/dialysis). Renal excretion negligible in anuric patients; biliary/fecal elimination not clinically relevant.
Category C
Category C
Dialysis Solution
Dialysis Solution